TRIGGIANESE, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 14.711
EU - Europa 1.252
AS - Asia 878
AF - Africa 10
OC - Oceania 10
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.869
Nazione #
US - Stati Uniti d'America 14.685
SG - Singapore 506
CN - Cina 268
IT - Italia 240
IE - Irlanda 205
DE - Germania 148
UA - Ucraina 135
RU - Federazione Russa 133
FR - Francia 117
GB - Regno Unito 85
FI - Finlandia 59
KR - Corea 42
SE - Svezia 31
PL - Polonia 29
BE - Belgio 28
CA - Canada 18
IN - India 16
AU - Australia 9
AT - Austria 8
MX - Messico 8
ES - Italia 7
HK - Hong Kong 7
IR - Iran 7
TR - Turchia 6
UZ - Uzbekistan 6
VN - Vietnam 6
EG - Egitto 5
JP - Giappone 5
NL - Olanda 5
BR - Brasile 4
RO - Romania 4
SI - Slovenia 4
DK - Danimarca 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HR - Croazia 2
IQ - Iraq 2
MA - Marocco 2
NG - Nigeria 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BJ - Benin 1
CH - Svizzera 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
KG - Kirghizistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.869
Città #
Wilmington 4.093
Houston 3.648
Woodbridge 3.365
Fairfield 550
Ann Arbor 472
Singapore 437
Chandler 382
Ashburn 283
Seattle 236
Cambridge 178
Dublin 169
Medford 135
Santa Clara 109
Rome 102
New York 92
Jacksonville 84
Beijing 76
Lawrence 64
Zhengzhou 47
Dearborn 46
Redwood City 44
Moscow 33
Kraków 29
Brussels 27
Chengdu 24
San Diego 24
Nanjing 23
Seoul 22
Boardman 20
Menlo Park 20
Helsinki 17
Norwalk 15
Shanghai 15
London 14
Los Angeles 13
Palo Alto 13
Shenzhen 13
Bassano del Grappa 12
Scottsdale 12
Toronto 12
Lappeenranta 11
Milan 11
Center 9
Hefei 9
Kunming 9
Las Vegas 9
Chicago 8
Council Bluffs 7
Esslingen am Neckar 7
Mountain View 7
San Mateo 7
Falls Church 6
Guangzhou 6
Hong Kong 6
Dong Ket 5
Nuremberg 5
Phoenix 5
Williamsburg 5
Augusta 4
Brisbane 4
Cagliari 4
Engelhard 4
Enterprise 4
Espoo 4
Fuzhou 4
Hounslow 4
Indiana 4
Mexico City 4
Munich 4
Nanchang 4
Napoli 4
Pune 4
San Francisco 4
Verona 4
Amsterdam 3
Francavilla al Mare 3
Kilburn 3
Leawood 3
Melfa 3
Montreal 3
Padova 3
Rensselaer 3
Saint Petersburg 3
Shenyang 3
Siena 3
St. George 3
Sydney 3
Tivoli 3
Tokyo 3
Wuhan 3
Abuja 2
Acton 2
Cairo 2
Campos dos Goytacazes 2
Colorado Springs 2
Creede 2
Del Norte 2
Durham 2
Florence 2
Giza 2
Totale 15.234
Nome #
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 488
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 458
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 449
Vasculitides and the Complement System: a Comprehensive Review 439
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 434
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 432
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 431
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 428
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 420
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 416
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 416
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 409
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 408
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 407
Autoantibodies in inflammatory arthritis 400
HELLP syndrome: A complication or a new autoimmune syndrome? 399
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 384
Auto-reactions, autoimmunity and psoriatic arthritis 378
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 372
The interplay between inflammation and metabolism in rheumatoid arthritis 371
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 369
Insights on the role of physical activity in patients with rheumatoid arthritis 364
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 357
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 355
Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes 355
Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis 347
Long-term ustekinumab therapy of psoriasis in patients with coexisting rheumatoid arthritis and Sjögren syndrome. Report of two cases and review of literature 333
Systemic sclerosis: Exploring the potential interplay between thyroid disorders and pregnancy outcome in an Italian cohort 304
Effects of abatacept on T-lymphocyte sub-populations and immunoglobulins in patients affected by rheumatoid arthritis 298
Factors predicting 2 years of remission and low disease activity in rheumatoid arthritis patients treated with TNF-inhibitors 293
Hereditary angioedema and autoimmunity 290
null 287
Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study 280
Evidence for the detection of subclinical retinal involvement in systemic Lupus erythematosus and Sjögren syndrome: a potential association with therapies 277
Challenges in the treatment of Rheumatoid Arthritis 263
Interaction between microbiome and host genetics in psoriatic arthritis 236
Complement, infection, and autoimmunity 229
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 226
Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study 201
Take a look at the eyes in Systemic Lupus Erythematosus: A novel point of view 183
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets 181
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 167
A multimodal eye assessment in psoriatic arthritis patients sine-psoriasis: evidence for a potential association with systemic inflammation 165
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 164
Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: An optical coherence tomography angiography study 155
Evaluation of retinal microvascular perfusion in hereditary angioedema: A case-control study 154
Vitamin D deficiency in an Italian cohort of infertile women 142
Reproductive outcomes 20 years after the intravenous immunoglobulin treatment in women with recurrent pregnancy losses 129
Severe lupus nephritis: an unexpected association with Fabry disease 128
Immune checkpoint inhibitors-induced autoimmunity: the impact of gender 119
An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis 114
COVID-19: disCOVering the role of complement system 113
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 110
The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation? 104
Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 103
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary 97
Tackling the autoimmune side in Spondyloarthritis: a systematic review 97
Innate lymphoid cells: a potential innate functional equivalent of adaptive cells in infertility and inflammatory arthropathies 56
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis 54
Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections 46
Response to: 'OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE' by Mizuno et al 41
A rare but fatal behçet variant: the hughes–stovin syndrome—successful case report and new evidence from literature review 40
Two years follow-up of golimumab treatment in refractory enteropathic spondyloarthritis patients with Crohn disease: A STROBE-compliant study 34
A multilocus genetic study evidences the association of autoimmune-related genes with Psoriatic Arthritis in Italian patients 34
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management 33
Genetics, epigenetics, and gender impact in axial-spondyloarthritis susceptibility: an update on genetic polymorphisms and their sex related associations 33
Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis 28
Study of lncRNAs expression profile in the response to biological drugs in Psoriatic Arthritis: MEG3 could be a potential genomic biomarker of therapy efficacy 26
Rheumatologist's Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 26
Assessment of microvascular involvement in lupus nephritis patients by retinal OCT-angiography and kidney biopsies. 25
Subclinical microvascular changes in ANCA-vasculitides: the role of optical coherence tomography angiography and nailfold capillaroscopy in the detection of disease-related damage 25
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 23
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 23
The steroid-sparing effect of JAK inhibitors across multiple patient populations 23
What's new and what's next for biological and targeted synthetic treatments in psoriatic arthritis? 21
Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy 19
Human Leukocyte Antigen (HLA) Typing Study Identifies Maternal DQ2 Susceptibility Alleles among Infertile Women: Potential Associations with Autoimmunity and Micronutrients 19
Evaluation of diagnostic and therapeutic delay in patients with rheumatoid arthritis and psoriatic arthritis 19
Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease 19
Pregnancy in women with Hereditary Angioedema due to C1-inhibitor deficiency: Results from the ITACA cohort study on outcome of mothers and children with in utero exposure to plasma-derived C1-inhibitor 18
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 17
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 16
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry (Internal and Emergency Medicine, (2023), 18, 8, (2231-2243), 10.1007/s11739-023-03408-3) 16
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 15
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 15
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 15
Subclinical signs of retinal involvement in hereditary angioedema 15
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 13
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies 13
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 11
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 10
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 9
Psoriatic Arthritis in Males and Females: Differences and Similarities 6
Totale 17.284
Categoria #
all - tutte 43.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.234 0 0 0 0 330 571 396 413 459 458 299 308
2020/20213.743 311 450 393 408 494 416 463 400 143 122 111 32
2021/2022717 44 64 61 39 37 43 36 39 37 61 83 173
2022/2023963 90 79 49 127 86 205 81 69 95 19 37 26
2023/2024468 38 16 20 13 71 103 14 58 22 25 24 64
2024/20251.054 76 490 318 138 32 0 0 0 0 0 0 0
Totale 17.284